Momet GV 1mg/500mg/0.2mg Tablet SR
Marketer
Theogen Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Momet GV 1mg/500mg/0.2mg Tablet SR
Diabeva Trio 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabeva Trio should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan that incorporates a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician prior to initiating treatment. Pregnant or breastfeeding women require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to evaluate blood cell counts and liver function.
Primary Ingredients of Momet GV 1mg/500mg/0.2mg Tablet SR
No information provided. Please provide the text you wish to be rephrased.
Uses of Momet GV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Momet GV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume Momet GV 1mg/500mg/0.2mg Extended-Release tablets on an empty stomach.
Common Side effects of Momet GV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Momet GV 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Momet GV 1mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or divide the tablet. Administer on an empty stomach.
How Momet GV 1mg/500mg/0.2mg Tablet SR works:
Each Momet GV SR tablet (1mg/500mg/0.2mg) contains a triple-action antidiabetic formula.
SAFETY ADVICE
AlcoholUNSAFE
Combining Momet GV 1mg/500mg/0.2mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Momet GV 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Momet GV 1mg/500mg/0.2mg extended-release tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose levels are abnormally low or elevated. Refrain from driving should these conditions arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Momet GV 1mg/500mg/0.2mg Tablet SR, as its use may be unsafe. Medical advice should be sought before using this medication. The use of Momet GV 1mg/500mg/0.2mg Tablet SR is discouraged for individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Momet GV 1mg/500mg/0.2mg SR tablets cautiously, as dosage modification may be necessary. Individuals with mild to moderate liver disease should begin with a reduced dose; however, the medication is contraindicated in those with severe hepatic dysfunction. Physician consultation is advised.
What if you forget to take Momet GV 1mg/500mg/0.2mg Tablet SR :
Should you forget a dose of your Momet GV 1mg/500mg/0.2mg SR Tablet, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your normal dosing routine. Never take more than the prescribed dose.
Facts to Know About Momet GV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently